AU6503899A - 2-(2,3-dihydrobenzofuran-5-yl)-4-aminomethylimidazoles: dopamine receptor subtype specific ligands - Google Patents

2-(2,3-dihydrobenzofuran-5-yl)-4-aminomethylimidazoles: dopamine receptor subtype specific ligands

Info

Publication number
AU6503899A
AU6503899A AU65038/99A AU6503899A AU6503899A AU 6503899 A AU6503899 A AU 6503899A AU 65038/99 A AU65038/99 A AU 65038/99A AU 6503899 A AU6503899 A AU 6503899A AU 6503899 A AU6503899 A AU 6503899A
Authority
AU
Australia
Prior art keywords
aminomethylimidazoles
dihydrobenzofuran
dopamine receptor
receptor subtype
specific ligands
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU65038/99A
Inventor
Xi Chen
Xiao-Shu He
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Neurogen Corp
Original Assignee
Neurogen Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neurogen Corp filed Critical Neurogen Corp
Publication of AU6503899A publication Critical patent/AU6503899A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AU65038/99A 1998-09-29 1999-09-29 2-(2,3-dihydrobenzofuran-5-yl)-4-aminomethylimidazoles: dopamine receptor subtype specific ligands Abandoned AU6503899A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US16286198A 1998-09-29 1998-09-29
US09162861 1998-09-29
PCT/US1999/022699 WO2000018763A2 (en) 1998-09-29 1999-09-29 2-(2,3-dihydrobenzofuran-5-yl)-4-aminomethylimidazoles: dopamine receptor subtype specific ligands

Publications (1)

Publication Number Publication Date
AU6503899A true AU6503899A (en) 2000-04-17

Family

ID=22587429

Family Applications (1)

Application Number Title Priority Date Filing Date
AU65038/99A Abandoned AU6503899A (en) 1998-09-29 1999-09-29 2-(2,3-dihydrobenzofuran-5-yl)-4-aminomethylimidazoles: dopamine receptor subtype specific ligands

Country Status (2)

Country Link
AU (1) AU6503899A (en)
WO (1) WO2000018763A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2436699A1 (en) * 2000-12-21 2002-06-27 Warner-Lambert Company Llc Piperidine derivatives as subtype selective n-methyl-d-aspartate antagonists

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7017486A (en) * 1969-12-15 1971-06-17
US5159083A (en) * 1990-12-28 1992-10-27 Neurogen Corporation Certain aminomethyl phenylimidazole derivatives; a class of dopamine receptor subtype specific ligands
US5681956A (en) * 1990-12-28 1997-10-28 Neurogen Corporation 4-aryl substituted piperazinylmethyl phenylimidazole derivatives; a new class of dopamine receptor subtype specific ligands
AU4368996A (en) * 1994-11-23 1996-06-17 Neurogen Corporation Certain 4-aminomethyl-2-substituted imidazole derivatives and 2-aminomethyl-4-substituted imidazole derivatives; new classes of dopamine receptor subtype specific ligands
WO1996016057A1 (en) * 1994-11-23 1996-05-30 Neurogen Corporation Certain 1-substituted aminomethyl imidazole and pyrrole derivatives; novel dopamine receptor subtype specific ligands
TW504510B (en) * 1996-05-10 2002-10-01 Janssen Pharmaceutica Nv 2,4-diaminopyrimidine derivatives

Also Published As

Publication number Publication date
WO2000018763A2 (en) 2000-04-06
WO2000018763A3 (en) 2000-05-25

Similar Documents

Publication Publication Date Title
AU4802500A (en) 2-aminoquinolinecarboxamides: neurokinin receptor ligands
HUP9901436A3 (en) N-aminoalkylfluorenecarboxamides as dopamine receptor subtype ligands
ZA200100900B (en) 2-substituted-1-piperidyl benzimidazole compounds as orl1-receptor agonists.
AU5203999A (en) Beta3-adrenergic receptor agonists
AU2001280568A1 (en) Heterocyclic beta-3 adrenergic receptor agonists
AU7445900A (en) Novel hemopoietin receptor protein, nr12
HUP9903445A3 (en) 2,4-diaminopyrimidine derivates as dopamine d4 receptor antagonists
AU4057097A (en) Fused indolecarboxamides: dopamine receptor subtype specific ligands
AU8096798A (en) Dopamine d4 receptor ligands
AU775774C (en) Peroxisome proliferator-activated receptor agonist
AU8457298A (en) 2-(4-aryl or heteroaryl-piperazin-1-ylmethyl)-1H-indole derivatives interacting with the dopamine D4 receptor
ID28483A (en) 2- (3,5-BIS-TRIFLUOROMETYL-PHENIL) -METIL-N- (6-MORFOLIN-4-IL-4-0-TOLYL-PYRIDIN-3-IL) -ISOBUTIRAMIDA
AU2001273508A1 (en) Heterocyclic beta-3 adrenergic receptor agonists
AU2001273542A1 (en) 2-substituted thiazolidinones as beta-3 adrenergic receptor agonists
AU5319700A (en) Nicotine receptor ligands
AU2738297A (en) Tricyclic aminoalkylcarboxamides; novel dopamine d3 receptor subtype specific ligands
HK1038749A1 (en) 2-piperazino alkylamino benzoazole derivatives: dopamine receptor subtype specific ligands
ZA992596B (en) Azabicyclic 5HT1 receptor ligands.
AU4312396A (en) Five-membered heteroaromatic compounds as dopamine receptor subtype ligands
AU2001259051A1 (en) Piperidyindoles as serotonin receptor ligands
GB9704376D0 (en) Tetrahydropyridine derivatives as dopamine receptor subtype ligands
IL128050A0 (en) Spirocyclic dopamine receptor subtype ligands
AU1286399A (en) 3-aminoalkylamino- 2h-1,4-benzoxazines and 3-aminoalkylamino- 2h-1,4-benzothiazines: dopamine receptor subtype specific ligands
AU1100300A (en) Piperidyloxadiazoles as dopamine receptor antagonists
AU2575399A (en) Oxazole derivatives as serotonin-1a receptor agonists

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase